|
Index | - | P/E | 22.76 | EPS (ttm) | 0.23 | Insider Own | 13.00% | Shs Outstand | 150.12M | Perf Week | 1.79% |
Market Cap | 768.61M | Forward P/E | - | EPS next Y | -1.31 | Insider Trans | 0.00% | Shs Float | 114.64M | Perf Month | -21.23% |
Income | 32.70M | PEG | - | EPS next Q | -0.01 | Inst Own | 49.90% | Short Float | 2.24% | Perf Quarter | -46.11% |
Sales | 438.90M | P/S | 1.75 | EPS this Y | -129.80% | Inst Trans | -0.31% | Short Ratio | 3.40 | Perf Half Y | -57.89% |
Book/sh | 4.47 | P/B | 1.15 | EPS next Y | -111.00% | ROA | - | Target Price | 9.88 | Perf Year | - |
Cash/sh | 2.73 | P/C | 1.88 | EPS next 5Y | - | ROE | - | 52W Range | 3.70 - 22.55 | Perf YTD | -61.82% |
Dividend | - | P/FCF | - | EPS past 5Y | - | ROI | 50.00% | 52W High | -77.29% | Beta | - |
Dividend % | - | Quick Ratio | - | Sales past 5Y | - | Gross Margin | 57.60% | 52W Low | 38.38% | ATR | 0.53 |
Employees | 1290 | Current Ratio | - | Sales Q/Q | 4628.90% | Oper. Margin | 33.40% | RSI (14) | 38.96 | Volatility | 6.24% 9.87% |
Optionable | Yes | Debt/Eq | - | EPS Q/Q | - | Profit Margin | 7.40% | Rel Volume | 0.70 | Prev Close | 4.95 |
Shortable | Yes | LT Debt/Eq | - | Earnings | May 11 AMC | Payout | 0.00% | Avg Volume | 755.93K | Price | 5.12 |
Recom | 2.00 | SMA20 | -13.56% | SMA50 | -22.49% | SMA200 | -45.48% | Volume | 531,173 | Change | 3.43% |
![]() |
|
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for public sectors, healthcare providers, large enterprises, and individual consumers. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System comprising a portable and reusable reader (Cue Reader), a single-use test cartridge (Cue Cartridge), and a sample collection wand (Cue Wand); Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows for integrations with third-party applications and sensors. Its diagnostic test for use with Cue Health Monitoring System is Cue COVID-19 Test Kit for ribonucleic acid of SARS-CoV-2, the virus that causes COVID-19. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
open in yahoo | open in reuters | open in marketwatch | open in google |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite